Royal DSM NV (DSM)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Royal DSM NV (DSM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011703
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Royal DSM NV (DSM) is a life sciences and materials sciences company, which focuses on health, nutrition and materials sectors. The company offers a wide range of products such as anti-invectives, polyesters, vitamins and other ingredients, performance materials to diverse end markets. It provides products and services to animal and human health and nutrition, personal care, pharmaceuticals, dietary supplements, automotive, medical materials, food and beverages, packaging, electrical and electronics, coatings and paints, alternative energy, housing, life protection and bio-based materials markets. It has operations in Europe, Americas, Africa, the Middle East and Asia Pacific. DSM is headquartered at Heerlen, the Netherlands.

Royal DSM NV (DSM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Royal DSM NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Royal DSM NV, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Royal DSM NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Royal DSM NV, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Royal DSM NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Royal DSM NV, Medical Equipment, Deal Details 10
Venture Financing 10
Essential Medical Raises USD15 Million in Series B Financing 10
Interface Biologics Raises Funds Through Extended Series B Venture Financing 11
Regentis Biomaterials Raises US$10 Million In Series C Financing 12
Partnerships 13
DSM Enters Into Licensing Agreement With SpineVision For Bionate II PCU 13
Royal DSM Extends Licensing Agreement With AxioMed Spine For CarboSil TSPCU 14
Royal DSM Enters Into Licensing Agreement With Svelte Medical Systems 15
Vention Medical Enters into Agreement with Royal DSM 16
Royal DSM Enters into Distribution Agreement with Sebbin 17
DSM Enters Into Agreement With Sayan Orthopaedics For Dyneema Purity Fiber 18
Royal DSM Forms Joint Venture With DuPont 19
DSM Dyneema Enters Into An Agreement With Proxy Biomedical 20
Debt Offering 21
Royal DSM Completes Public Offering Of Bonds Due 2024 For US$684 Million 21
Royal DSM Completes Private Placement Of Bonds Due 2019 For US$405 Million 22
Acquisition 23
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For US$360 Million 23
Royal DSM Sells Majority Stake In Qolpac 25
Royal DSM NV – Key Competitors 26
Royal DSM NV – Key Employees 27
Royal DSM NV – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Joint Venture 31
Recent Developments 33
Strategy And Business Planning 33
Apr 03, 2017: Royal DSM Opens New Biotechnology Center in Delft, the Netherlands 33
Financial Announcements 34
May 02, 2017: DSM Q1 2017 Results 34
Feb 15, 2017: DSM reports 2016 results 35
Feb 14, 2017: DSM new presentation of accounts as from Q4 2016 39
Aug 02, 2016: DSM Q2 2016 results 40
Corporate Communications 45
Feb 16, 2016: DSM Announces Eric Teutsch as President of DSM Biomedical 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Royal DSM NV, Medical Equipment, Key Facts, 2016 2
Royal DSM NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Royal DSM NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Royal DSM NV, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Royal DSM NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Royal DSM NV, Deals By Market, 2011 to YTD 2017 8
Royal DSM NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Essential Medical Raises USD15 Million in Series B Financing 10
Interface Biologics Raises Funds Through Extended Series B Venture Financing 11
Regentis Biomaterials Raises US$10 Million In Series C Financing 12
DSM Enters Into Licensing Agreement With SpineVision For Bionate II PCU 13
Royal DSM Extends Licensing Agreement With AxioMed Spine For CarboSil TSPCU 14
Royal DSM Enters Into Licensing Agreement With Svelte Medical Systems 15
Vention Medical Enters into Agreement with Royal DSM 16
Royal DSM Enters into Distribution Agreement with Sebbin 17
DSM Enters Into Agreement With Sayan Orthopaedics For Dyneema Purity Fiber 18
Royal DSM Forms Joint Venture With DuPont 19
DSM Dyneema Enters Into An Agreement With Proxy Biomedical 20
Royal DSM Completes Public Offering Of Bonds Due 2024 For US$684 Million 21
Royal DSM Completes Private Placement Of Bonds Due 2019 For US$405 Million 22
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For US$360 Million 23
Royal DSM Sells Majority Stake In Qolpac 25
Royal DSM NV, Key Competitors 26
Royal DSM NV, Key Employees 27
Royal DSM NV, Other Locations 28
Royal DSM NV, Subsidiaries 29
Royal DSM NV, Joint Venture 31

★海外企業調査レポート[Royal DSM NV (DSM)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■

◆H&Iグローバルリサーチ株式会社のお客様(例)◆